QyScore Analyzes MRIs for Biomarkers of Brain Diseases
Qynapse, a firm headquartered in Paris, France, won FDA clearance for its QyScore software that analyzes brain MRIs for biomarkers of central nervous system diseases. It’s intended to help diagnose and monitor diseases such as Alzheimer’s, Pa...
Source: Medgadget - Category: Medical Devices Authors: Medgadget Editors Tags: Diagnostics Informatics Neurology Radiology Source Type: blogs
More News: Brain | France Health | Hospitals | Medical Devices | Multiple Sclerosis | Neurology | PET Scan | Radiology